Skip to content

Effect of Hepatitis B Antibody and Blood Glucose Testing on Uptake of HIV, Syphilis, Hepatitis B, and Hepatitis C Screening Among Industrial workers: A Cluster Randomized Controlled Trial

Effect of Hepatitis B Antibody and Blood Glucose Testing on Uptake of HIV, Syphilis, Hepatitis B, and Hepatitis C Screening Among Industrial workers: A Cluster Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600127802
Enrollment
Unknown
Registered
2026-07-07
Start date
2026-07-13
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Interventions

Intervention group:Combined hepatitis B surface antibody and blood glucose testing offered alongside multiplex testing for HIV, HBV, HCV, and syphilis
Control group:No intervention

Sponsors

Guangxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18 years or older and younger than 65 years; 2. Industrial workers, defined as individuals engaged in production, processing, assembly, construction, or other related tasks in manufacturing enterprises or construction sites; 3. Willing to participate in the study and providing written informed consent.

Exclusion criteria

Exclusion criteria: 1. Self-reported receipt of HIV, syphilis, hepatitis B, and/or hepatitis C testing within the past 6 months; 2. Self-reported diagnosis of HIV infection/AIDS, syphilis, hepatitis B, or hepatitis C; 3. Individuals with contraindications to blood collection, including known bleeding disorders or anticoagulant therapy; 4. Unable to understand the study procedures (e.g., severe cognitive impairment, illiteracy with inability to comprehend study information independently); 5. Pregnant women; 6. Having a psychiatric disorder or other moderate-to-severe infectious or chronic diseases; 7. Currently participating in other related research studies.

Design outcomes

Primary

MeasureTime frame
Uptake of multiplex testing for HIV, HBV, HCV, and syphilis;

Secondary

MeasureTime frame
Uptake of testing for =1 but = 11.1 mmol/L);

Countries

China

Contacts

Public ContactBingyu Liang

Guangxi Medical University

liangbingyu@gxmu.edu.cn+86 180 7481 4940

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026